AwardedPOLGoods
Produkt leczniczy - Lisocabtagene Maraleucel
- Published
- Published 7 May 2026
Overview
The Institute of Hematology and Transfusion procured the medicinal product Lisocabtagene Maraleucel. The contract was awarded to Bristol-Myers Squibb Polska Sp. z o.o. and Urtica Sp.zo.o. for 7,788,960 PLN on 29 May 2026.
Key details
- Country
- POL
- Status
- Awarded
- Category
- Goods
- Procedure
- Direct
- Published
- 7 May 2026
Pharmaceutical products
Award outcome
- Awarded value
- PLN 7,788,960
- Award date
- 29 May 2026
- Contract period
- — → 24 May 2027
- Bristol-Myers Squibb Polska Sp. z o.o.
- Urtica Sp.zo.o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
26 June 2026
Contract Notice
7 May 2026
Contracting authority
Instytut Hematologii i Transfuzjologii
Procuring entityWarszawa, POL
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.